Clinical Trial Update: Rivaroxaban in Combination With Aspirin Alone or With Aspirin and a Thienopyridine in Patients With Acute Coronary Syndromes (The ATLAS ACS TIMI 46 Trial) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating rivaroxaban added to aspirin alone or with aspirin and a thienopyridine in patients with acute coronary syndrome; results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Aspirin (Aspirin)
• CLOPIDOGREL (CLOPIDOGREL)
• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Acute Coronary Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2012-08-29